![]() | This article reads like a press release or a news article and may be largely based on routine coverage. (December 2020) |
The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California.[1] The company consists of two business units, CooperVision (CVI) which manufactures contact lenses, and CooperSurgical (CSI), which manufactures medical devices and fertility and genomic products for the women's healthcare market.[2]
CooperCompanies was founded in 1958 as Martin H. Smith Co. and in 1961, incorporated as Cooper Tinsley Laboratories Inc. The company changed its name to Cooper Laboratories Inc. in 1967,[3] and entered the contact lens business when it acquired British lens maker GlobalVision in 1972.[4]
In 1980, Cooper Laboratories reorganized into three business groups: CooperVision, CooperCare and CooperBiomedical, with Cooper Medical Devices Corp. added as a fourth group one year later.[citation needed]
The company was renamed The Cooper Companies in 1987. Three years later, it was further restructured into three business units: CooperVision, CooperSurgical and CooperVision Pharmaceuticals (dissolved in 2003).
Currently, the firm operates as two business units: CooperVision and CooperSurgical.[5] CooperVision serves contact lens wearers and eye care practitioners.[6] Products include a range of daily, two-week and monthly disposable contact lenses, and other spherical, toric and multifocal lenses for astigmatism, nearsightedness and farsightedness, and presbyopia.[7]
CooperSurgical is the medical device and fertility and genomics unit of the companies. It became a business unit in 1990 and its focus includes women's health and fertility.[8][9]
Ocular Sciences Inc. was acquired by CooperVision in 2005.[10]
CooperSurgical acquired AEGEA Medical, a medical manufacturing company in February 2021.[11] A month later, in March, the company acquired Safe Obstetric Systems[12][9], and in December 2021, CooperSurgical acquired Generate Life Sciences for $1.6 billion.[13]
In March 2022, CooperSurgical acquired Cook Medical's reproductive health business for $875 million.[14] During that same year the company acquired EnsEyers, a supplier of orthokeratology and scleral contact lenses.[15]